Moody's
Agilent Prices Public Offering of Senior Notes at $400M
NEW YORK (GenomeWeb News) – Agilent Technologies priced its public offering of senior notes at an aggregate principal amount of $400 million after the close of the market on Monday. The notes will mature in October 2022 and bear interest at an annual rate of 3.20 percent.
Moody's Downgrades Thermo Fisher on Plan to Buy One Lambda
NEW YORK (GenomeWeb News) – Following Thermo Fisher Scientific's announcement today that it is buying One Lambda for $925 million, ratings agency Moody's Investors Service downgraded the company's s
Moody's Upgrades Life Technologies' Senior Notes
NEW YORK (GenomeWeb News) – Moody's Investors Service has upgraded $2.3 billion of Life Technologies' Senior Unsecured Notes to investment grade from speculative grade.
Earlier this month the California Institute for Regenerative Medicine said it plans to privately sell $200 million in bonds in this and the following fiscal year in case it will be unable to access public capital.